Wallaby Medical Avenir^® Coil System Receives China NMPA Approval

LAGUNA HILLS, CA and SHANGHAI - Aug. 21, 2021-Wallaby Medical, a medical technology company focusing on developing and commercializing products to prevent and treat stroke, announced that the Avenir^® Coil System, a product independently developed by Wallaby Medical, was recently approved by the China National Medical Products Administration (NMPA). Avenir^® Coil System is used for intravascular embolization of intracranial aneurysms and other neurovascular malformations (such as arteriovenous malformations and arteriovenous fistulas), as well as arterial and venous embolization of peripheral blood vessels.

Picture source：China National Medical Product Administration Website

According to the "Health Statistics Yearbook 2020", neurovascular disease mortality ranks No.3 among the main disease mortality in China, of which accounting for up to 20.61% of the total count. Neurovascular disease severely threatens the health and well-being of Chinese residents. Wallaby Medical, as an international medical device company with offices in Shanghai and Laguna hills, has been on the forefront of innovating and commercializing a full range of products for diagnosing and treating neurovascular disease, with the goal of working with the Chinese physician community to save the greatest number of lives affected by stroke.

Image copyright is of Wallaby Medical

Avenir^® Coil System is designed with three outstanding advantages: complex framing coils、ultra-soft finishing coils、and instant coil detachment. With a complete product series including stable framing coils, ultra-volume filling coils, and ultra-soft finishing coils, Avenir^® enables the physicians to perform endovascular embolization of intracranial aneurysms and other neurovascular malformations (such as arteriovenous malformations and arteriovenous fistulas), as well as arterial and venous embolization of peripheral blood vessels. The reduced coil first loop diameter minimizes coil herniation during coil introduction into the aneurysm. The exceptional framing coils provide excellent aneurysm wall apposition and coil distribution to facilitate dense packing. In addition, ultra-soft finishing coils manufactured from ultra-fine primary wire enhance softness and conformability, allowing for optimal space seeking capability for the deployed coils to realize higher packing density. 

"Wallaby Medical is focused on providing a full range of neuro intervention medical device products for the physician community, leveraging our strong R&D capabilities to develop products with excellent performance and technical differentiation. Avenir^® Coil System is a prime example of us providing physicians the best possible products to allow them to improve patient outcomes. Avenir^® has already been commercialized in more than 30 countries and regions around the world, and we are extremely excited to be able to bring this offering to Chinese physicians. China is crucial to Wallaby's continued growth, and we are honored to be able to have this product save lives affected by stroke in China", said Michael Alper, CEO, Wallaby Medical.

Image copyright is of Wallaby Medical

About Wallaby Medical,

Wallaby Medical focuses on developing and commercializing medical device products for treating stroke. Wallaby's products include the Avenir^® Coil System which is a technically differentiated neuro embolic coil system for treating intracranial aneurysms and other neurovascular abnormalities and the Esperance™ DAC catheter for the delivery of therapeutic devices during ischemic stroke and hemorrhagic stroke procedures. In addition, Esperance™ ASP catheter has obtaiend FDA 510K clearance. Wallaby's products are commercialized in over 30 countries and regions. For more information, visit: www.wallabymedical.com.